Literature DB >> 17255202

Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I.

Laura A Maile1, Byron E Capps, Yan Ling, Gang Xi, David R Clemmons.   

Abstract

IGF-I stimulation of smooth muscle cell (SMC) migration and proliferation requires alphaVbeta3 ligand occupancy. We hypothesized that changes in the levels of extracellular matrix proteins induced by alterations in glucose concentrations may regulate the ability of SMCs to respond to IGF-I. IGF-I stimulated migration and proliferation of SMCs that had been maintained in 25 mM glucose containing media, but it had no stimulatory effect when tested using SMCs that had been grown in 5 mM glucose. IGF-I stimulated an increase in Shc phosphorylation and enhanced activation of the MAPK pathway in SMCs grown in 25 mM glucose, whereas in cells maintained in 5 mM glucose, IGF-I had no effect on Shc phosphorylation, and the MAPK response to IGF-I was markedly reduced. In cells grown in 25 mM glucose, the levels of alphaVbeta3 ligands, e.g. osteopontin, vitronectin, and thrombospondin, were all significantly increased, compared with cells grown in 5 mM glucose. The addition of these alphaVbeta3 ligands to SMCs grown in 5 mM glucose was sufficient to permit IGF-I-stimulated Shc phosphorylation and downstream signaling. Because we have shown previously that alphaVbeta3 ligand occupancy is required for IGF-I-stimulated Shc phosphorylation and stimulation of SMC growth, our data are consistent with a model in which 25 mM glucose stimulates increases in the concentrations of these extracellular matrix proteins, thus enhancing alphaVbeta3 ligand occupancy, which leads to increased Shc phosphorylation and enhanced cell migration and proliferation in response to IGF-I.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255202     DOI: 10.1210/en.2006-1440

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  35 in total

1.  Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.

Authors:  Gang Xi; Xinchun Shen; Yashwanth Radhakrishnan; Laura Maile; David Clemmons
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  A monoclonal antibody against alphaVbeta3 integrin inhibits development of atherosclerotic lesions in diabetic pigs.

Authors:  Laura A Maile; Walker H Busby; Timothy C Nichols; Dwight A Bellinger; Elizabeth P Merricks; Michael Rowland; Umadevi Veluvolu; David R Clemmons
Journal:  Sci Transl Med       Date:  2010-02-10       Impact factor: 17.956

3.  PDK1 recruitment to the SHPS-1 signaling complex enhances insulin-like growth factor-i-stimulated AKT activation and vascular smooth muscle cell survival.

Authors:  Xinchun Shen; Gang Xi; Yashwanth Radhakrishnan; David R Clemmons
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

4.  Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization.

Authors:  Gang Xi; Xinchun Shen; Christine Wai; Morris F White; David R Clemmons
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

5.  Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability.

Authors:  Shaw-Yung Shai; Sergiy Sukhanov; Yusuke Higashi; Charlotte Vaughn; James Kelly; Patrice Delafontaine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07-29       Impact factor: 8.311

6.  Identification of novel SHPS-1-associated proteins and their roles in regulation of insulin-like growth factor-dependent responses in vascular smooth muscle cells.

Authors:  Xinchun Shen; Gang Xi; Yashwanth Radhakrishnan; David R Clemmons
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

7.  Relative resistance to Mammalian target of rapamycin inhibition in vascular smooth muscle cells of diabetic donors.

Authors:  Daniel J Lightell; T Cooper Woods
Journal:  Ochsner J       Date:  2013

8.  Identification of compounds that inhibit IGF-I signaling in hyperglycemia.

Authors:  Laura A Maile; Lee B Allen; Umadevi Veluvolu; Byron E Capps; Walker H Busby; Michael Rowland; David R Clemmons
Journal:  Exp Diabetes Res       Date:  2010-01-06

9.  Glucose regulation of thrombospondin and its role in the modulation of smooth muscle cell proliferation.

Authors:  Laura A Maile; Lee B Allen; Christopher F Hanzaker; Katherine A Gollahon; Paul Dunbar; David R Clemmons
Journal:  Exp Diabetes Res       Date:  2010-06-20

10.  Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I.

Authors:  Laura A Maile; Byron E Capps; Emily C Miller; Lee B Allen; Umadevi Veluvolu; Ariel W Aday; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.